ChemicalBook >>Ganciclovir>>9-(1,3-Dihydroxy-2-propoxymethyl)guanine(82410-32-0)

9-(1,3-Dihydroxy-2-propoxymethyl)guanine(82410-32-0)

9-(1,3-Dihydroxy-2-propoxymethyl)guanine(82410-32-0)
Product IdentificationBack to Contents
【Product Name】

9-(1,3-Dihydroxy-2-propoxymethyl)guanine
【Synonyms】

2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-h-purin-6-one
2-Amino-9-((1,4-dihydroxybutan-2-yloxy)methyl)-3H-purin-6(9H)-one
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-
9-(1,3-Dihydroxy-2-propoxymethyl)guanine
Cymevan
Hydroxyacyclovir
【CAS】

82410-32-0
【Formula】

C9H13N5O4
【Molecular Weight】

255.23
【RTECS】

MF8407000
【RTECS Class】

Drug; Mutagen
【Merck】

12,4374
【Beilstein/Gmelin】

3654487
Physical and Chemical PropertiesBack to Contents
【Appearance】

Crystals from methanol.
【Solubility in water】

Very soluble
【Melting Point】

250
【pKa/pKb】

9.15 (pKa)
【Partition Coefficient】

-2.07
【Heat Of Vaporization】

【Usage】

Medication.
First Aid MeasuresBack to Contents
【Ingestion】

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
【Inhalation】

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
【Skin】

Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
【Eyes】

Manufacturer recommendations include caution in handling ganciclovir formulations (intravenous {alkaline ph 11} or oral) and to avoid direct contact with skin or mucous membranes.
Handling and StorageBack to Contents
【Storage】

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
【Handling】

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards IdentificationBack to Contents
【Inhalation】

Pneumonia, dyspnea, and cough have been reported with ganciclovir.
【Skin】

Pruritus, rash, and sweating were the most frequent dermatologic complaints associated with intravenous or oral ganciclovir.
【Ingestion】

Vomiting, diarrhea, and anorexia have been reported in clinical trials. Upper gastrointestinal bleeding has occurred following ganciclovir therapy.
Exposure Controls/Personal ProtectionBack to Contents
【Personal Protection】

Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
【Respirators】

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
【Exposure Effects】

Fever has occurred with ganciclovir therapy. neuropathy and paresthesia have occurred during clinical trials with immunocompromised patients. Seizures associated with ganciclovir use have also occurred. Ganciclovir is classified by the manufacturer as US FDA pregnancy category C.
Fire Fighting MeasuresBack to Contents
【Fire Fighting】

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Accidental Release MeasuresBack to Contents
【Small spills/leaks】

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability and ReactivityBack to Contents
【Stability】

Exposure to temperatures exceeding 40 C should be avoided. When stored as directed, the sterile powder has an expiration date of 3 years following the date of manufacture.
【Incompatibilities】

Strong oxidizing agents.
Company Name: AnHui HaiKang Pharmaceutical Co., Ltd.
Tel: 0556-5800026 17709662922
Fax:
WebSite: http://www.hkpharm.cn
Company Name: Jiangxi ravel Biotechnology Co.,Ltd
Tel: 400-880-2824 15608648206
Fax:
WebSite: https://www.ruiweier.cn
Company Name: Hubei Yuanmeng Biotechnology Co., Ltd
Tel: 027-68897569 18120462897
Fax: 027-68897569
WebSite: http://www.ymswkjgs.com/
Company Name: Hangzhou Xiao Bei Medical Technology Co., LTD
Tel: +86-571-8526 3177 13962438025
Fax:
WebSite: www.heryipharma.com
Company Name: J & K SCIENTIFIC LTD.
Tel: 010-82848833 400-666-7788
Fax: 86-10-82849933
WebSite: http://www.jkchemical.com
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.
Tel: 821-50328103-801 18930552037
Fax: 86-21-50328109
WebSite: https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm
Company Name: TAIYUAN RHF CO.,LTD.
Tel: +86 351 7031519
Fax: +86 351 7031519
WebSite: www.rhfchem.com
Company Name: TCI (Shanghai) Development Co., Ltd.
Tel: 021-67121386
Fax: 021-67121385
WebSite: https://www.tcichemicals.com/CN/zh/